• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up2.27% Nasdaq Up2.45%

    Halozyme Therapeutics, Inc. (HALO)

    -NasdaqGS
    18.04 Up 0.58(3.32%) 4:00PM EDT
    |After Hours : 18.10 Up 0.06 (0.33%) 6:04PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingJun 30, 2015Mar 31, 2015Dec 31, 2014Sep 30, 2014
    Total Revenue 43,384   18,666   30,377   14,606  
    Cost of Revenue8,144  6,494  6,147  5,141  
    Gross Profit 35,240   12,172   24,230   9,465  
    Operating Expenses
    Research Development21,195  16,684  19,728  19,904  
    Selling General and Administrative9,814  9,399  8,353  8,587  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 4,231   (13,911) (3,851) (19,026)
    Income from Continuing Operations
    Total Other Income/Expenses Net87  102  (45)122  
    Earnings Before Interest And Taxes4,318  (13,809)(3,896)(18,904)
    Interest Expense1,299  1,299  1,378  1,376  
    Income Before Tax3,019  (15,108)(5,274)(20,280)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops3,019  (15,108)(5,274)(20,280)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 3,019   (15,108) (5,274) (20,280)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 3,019   (15,108) (5,274) (20,280)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.